Prognostic value of innate and adaptive immunity in colorectal cancer.
about
Dendritic cell-based cancer immunotherapy for colorectal cancerImmune cells: plastic players along colorectal cancer progressionPlasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African AmericansMPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal LesionsBiomarkers in precision therapy in colorectal cancer.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.The potential role of immunotherapy to treat colorectal cancer.Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.Checkpoint inhibition for colorectal cancer: progress and possibilities.Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer.Cancer heterogeneity and drug metabolism: what we know and what we need to know.
P2860
Q26751339-8B06F3AD-F3C2-43C1-BECD-210B84151A8EQ33985586-4A2B41FD-36EA-4C37-92F0-01B8B2A35CA4Q35101910-B3D94E1F-1BC8-456B-8CAE-1C47355A6FFBQ35474078-5F47A4B2-C793-415A-A843-F3281BA075BEQ35855391-AE213A03-21C1-4106-B46D-06EF95A81E1CQ36054462-49BD70A2-8285-4161-A58C-40FF0D9F3175Q36105442-ED404E4F-C941-432D-87B6-4FDAB1213C58Q36255726-511175A6-5755-4721-AF6B-1A79F2B88603Q36918121-7E7DEF3E-274D-4974-877F-F4661A559FADQ37115232-26A6CBF5-062B-4B18-8C18-90D0AA4EDB46Q37609130-B18AEA2C-1170-4420-B212-3313E4210C2DQ37697529-9CB8A55F-6508-4C57-80F7-8C82B0A1AC27Q38292169-9D02AAD5-AA01-4500-8AEE-D1A4AF9E5C7DQ38630131-8BC6AC6B-09BF-4B96-9A47-06C5CA54D5A8Q38838641-524BD38F-6164-409A-801D-3B244EE1F8CEQ39682144-052CBEBF-5A7F-4DB8-98D0-55A6277D583AQ40873602-2CA14621-DC2D-4966-9806-C10F52BF1637Q44032656-06BC7776-F942-4149-90AB-5C99AA63B798
P2860
Prognostic value of innate and adaptive immunity in colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prognostic value of innate and adaptive immunity in colorectal cancer.
@ast
Prognostic value of innate and adaptive immunity in colorectal cancer.
@en
type
label
Prognostic value of innate and adaptive immunity in colorectal cancer.
@ast
Prognostic value of innate and adaptive immunity in colorectal cancer.
@en
prefLabel
Prognostic value of innate and adaptive immunity in colorectal cancer.
@ast
Prognostic value of innate and adaptive immunity in colorectal cancer.
@en
P2093
P2860
P356
P1476
Prognostic value of innate and adaptive immunity in colorectal cancer.
@en
P2093
Alberto Malesci
Fabio Grizzi
Luigi Laghi
Paolo Bianchi
P2860
P304
P356
10.3748/WJG.V19.I2.174
P407
P577
2013-01-01T00:00:00Z